Cardiac Changes in Horses with Atypical Myopathy

Journal of Veterinary Internal Medicine

Volumn 26, Issue 4, 2012, Pages 1019-1026

  Verheyen, T ^a   Decloedt, A ^a   de Clercq, D ^a   van Loon, G ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Cardiac dysrhythmia; Cardiac ultrasound; QT interval; Rhabdomyolysis; Tissue Doppler imaging

Indexed keywords

TROPONIN I;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HORSE; HORSE DISEASE; MALE; PATHOPHYSIOLOGY; RHABDOMYOLYSIS;

ANIMALS; ARRHYTHMIAS, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HORSE DISEASES; HORSES; MALE; RHABDOMYOLYSIS; TROPONIN I;

ANIMALIA; EQUIDAE;

EID: 84863995414     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.00945.x     Document Type: Article

References (38)

1. Votion DM, Serteyn D. Equine atypical myopathy: A review. Vet J 2008;178:185-190.
2. Linklater KA. Myopathy in horses and ponies. Vet Rec 1984;115:666-666.
3. Anonymous. Atypical myoglobinuria: A new disease in horses? Vet Rec 1985;116:86-87.
4. Finno CJ, Valberg SJ, Wunschmann A, et al. Seasonal pasture myopathy in horses in the midwestern United States: 14 cases (1998-2005). J Am Vet Med Assoc 2006;229:1134-1141.
5. Unger-Torroledo L, Straub R, Lehmann AD, et al. Lethal toxin of Clostridium sordellii is associated with fatal equine atypical myopathy. Vet Microbiol 2010;144:487-492.
6. Westermann CM, Dorland L, Votion DM, et al. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy. Neuromuscul Disord 2008;18:355-364.
7. van der Kolk JH, Wijnberg ID, Westermann CM, et al. Equine acquired multiple acyl-CoA dehydrogenase deficiency (MADD) in 14 horses associated with ingestion of maple leaves (Acer pseudoplatanus) covered with European tar spot (Rhytisma acerinum). Mol Genet Metab 2010;101:289-291.
8. Cassart D, Baise E, Cherel Y, et al. Morphological alterations in oxidative muscles and mitochondrial structure associated with equine atypical myopathy. Equine Vet J 2007;39:26-32.
9. Kraus MS, Jesty SA, Gelzer AR, et al. Measurement of plasma cardiac troponin I concentration by use of a point-of-care analyzer in clinically normal horses and horses with experimentally induced cardiac disease. Am J Vet Res 2010;71:55-59.
10. Votion D-M, Linden A, Saegerman C, et al. History and clinical features of atypical myopathy in horses in Belgium (2000-2005). J Vet Intern Med 2007;21:1380-1391.
11. Patteson MW, Gibbs C, Wotton PR, et al. Echocardiographic measurements of cardiac dimensions and indices of cardiac function in normal adult Thoroughbred horses. Equine Vet J 1995;27:18-27.
12. Decloedt A, Verheyen T, Sys S, et al. Quantification of left ventricular longitudinal strain, strain rate, velocity, and displacement in healthy horses by 2-dimensional speckle tracking. J Vet Intern Med 2011;25:330-338.
13. Schwarzwald CC, Schober KE, Berli ASJ, et al. Left ventricular radial and circumferential wall motion analysis in horses using strain, strain rate, and displacement by 2D speckle tracking. J Vet Intern Med 2009;23:890-900.
14. Davey P. How to correct the QT interval for the effects of heart rate in clinical studies. J Pharmacol Toxicol Methods 2002;48:3-9.
15. Schwarzwald CC, Hamlin RL, Bonagura JD, et al. Atrial, SA nodal, and AV nodal electrophysiology in standing horses: Normal findings and electrophysiologic effects of quinidine and diltiazem. J Vet Intern Med 2007;21:166-175.
16. Haugaa KH, Amlie JP, Berge KE, et al. Transmural differences in myocardial contraction in long-QT syndrome mechanical consequences of ion channel dysfunction. Circulation 2010;122:1355-1363.
17. Jesty SA, Kraus M, Gelzer A, et al. Effect of transvenous electrical cardioversion on plasma cardiac troponin I concentrations in horses with atrial fibrillation. J Vet Intern Med 2009;23:1103-1107.
18. Mangoni AA, Kinirons MT, Swift CG, et al. Impact of age on QT interval and QT dispersion in healthy subjects: A regression analysis. Age Ageing 2003;32:326-331.
19. Finley MR, Lillich JD, Gilmour RF, et al. Structural and functional basis for the long QT syndrome: Relevance to veterinary patients. J Vet Intern Med 2003;17:473-488.
20. Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med 2002;112:58-66.
21. El-Sherif N, Turitto G. The long QT syndrome and torsade de pointes. Pacing Clin Electrophysiol 1999;22:91-110.
22. Borer KE, Corley KTT. Electrolyte disorders in horses with colic. Part 1: Potassium and magnesium. Equine Vet Educ 2006;18:266-271.
23. Borer KE, Corley KTT. Electrolyte disorders in horses with colic. Part 2: Calcium, sodium, chloride and phosphate. Equine Vet Educ 2006;18:320-325.
24. Gelinas R, Thompson-Legault J, Bouchard B, et al. Prolonged QT interval and lipid alterations beyond beta-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts. Am J Physiol Heart Circ Physiol 2011;301:H813-H823.
25. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 1999;99:2452-2457.
26. Mozaffarian D, Prineas RJ, Stein PK, et al. Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 2006;48:478-484.
27. Werdich AA, Baudenbacher F, Dzhura I, et al. Polymorphic ventricular tachycardia and abnormal Ca2 + handling in very-long-chain acyl-CoA dehydrogenase null mice. Am J Physiol Heart Circ Physiol 2007;292:H2202-H2211.
28. + current. Circ Res 1989;64:977-990.
29. Hirano Y, Moscucci A, January CT. Direct measurement of L-type Ca2 + window current in heart cells. Circ Res 1992;70:445-455.
30. De Ferrari GM, Nador F, Beria G, et al. Effect of calcium-channel block on the wall-motion abnormality of the idiopathic long QT syndrome. Circulation 1994;89:2126-2132.
31. Citro R, Galderisi M. Myocardial postsystolic motion in ischemic and not ischemic myocardium: The clinical value of tissue Doppler. Echocardiography 2005;22:525-532.
32. Voigt JV, Lindenmeier G, Exner B, et al. Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium. J Am Soc Echocardiogr 2003;16:415-423.
33. Nador F, Beria G, De Ferrari GM, et al. Unsuspected echocardiographic abnormality in the long QT syndrome. Diagnostic, prognostic, and pathogenetic implications. Circulation 1991;84:1530-1542.
34. Savoye C, Klug D, Denjoy I, et al. Tissue Doppler echocardiography in patients with long QT syndrome. Eur J Echocardio 2003;4:209-213.
35. Rivas-Gotz C, Khoury DS, Manolios M, et al. Time interval between onset of mitral inflow and onset of early diastolic velocity by tissue Doppler: A novel index of left ventricular relaxation-Experimental studies and clinical application. J Am Coll Cardiol 2003;42:1463-1470.
36. Schefer KD, Hagen R, Ringer SK, et al. Laboratory, electrocardiographic, and echocardiographic detection of myocardial damage and dysfunction in an Arabian mare with nutritional masseter myodegeneration. J Vet Intern Med 2011;25:1171-1180.
37. Haugaa KH, Edvardsen T, Leren TP, et al. Left ventricular mechanical dispersion by tissue Doppler imaging: A novel approach for identifying high-risk individuals with long QT syndrome. Eur Heart J 2009;30:330-337.
38. Nakayama K, Yamanari H, Otsuka F, et al. Dispersion of regional wall motion abnormality in patients with long QT syndrome. Heart 1998;80:245-250.